Model Portfolios
News
Contact
  • Our ETFs
  • Insights
  • How to Invest
  • About Us
  • A Conversation About Personalized Medicine with Luba Greenwood

    Dec 15, 2022

    View all Global X Research Team's ArticlesGlobal X Research TeamGlobal X Research Team

    Preview



    Lis Agosto (Research Analyst at Global X ETFs) sits down with Luba Greenwood (CEO of Kojin Therapeutics) to discuss the state of the healthcare industry today and where it is headed.

    https://partners.wsj.com/global-x-etfs/charting-disruption/personalized-medicine

    Share
    Category:Thematic Growth
    Topics:
    Disruptive Technology,
    Health Care,
    Biotechnology,
    Genomics,
    Multimedia

    RELATED ARTICLES

    The Next Big Theme: May 2025

    Why Cybersecurity? Why BUG?

    Why Multi-Theme Investing? Why GXDW?

    Why HealthTech? Why HEAL?